Literature DB >> 28774878

The actin-binding protein profilin 2 is a novel regulator of iron homeostasis.

Sara Luscieti1,2, Bruno Galy3, Lucia Gutierrez4, Michael Reinke5, Jorge Couso1,2, Maya Shvartsman1, Antonio Di Pascale6, Walter Witke5, Matthias W Hentze7, Pietro Pilo Boyl5, Mayka Sanchez1,2.   

Abstract

Cellular iron homeostasis is controlled by the iron regulatory proteins (IRPs) 1 and 2 that bind cis-regulatory iron-responsive elements (IRE) on target messenger RNAs (mRNA). We identified profilin 2 (Pfn2) mRNA, which encodes an actin-binding protein involved in endocytosis and neurotransmitter release, as a novel IRP-interacting transcript, and studied its role in iron metabolism. A combination of electrophoretic mobility shift assay experiments and bioinformatic analyses led to the identification of an atypical and conserved IRE in the 3' untranslated region of Pfn2 mRNA. Pfn2 mRNA levels were significantly reduced in duodenal samples from mice with intestinal IRP ablation, suggesting that IRPs exert a positive effect on Pfn2 mRNA expression in vivo. Overexpression of Pfn2 in HeLa and Hepa1-6 cells reduced their metabolically active iron pool. Importantly, Pfn2-deficient mice showed iron accumulation in discrete areas of the brain (olfactory bulb, hippocampus, and midbrain) and reduction of the hepatic iron store without anemia. Despite low liver iron levels, hepatic hepcidin expression remained high, likely because of compensatory activation of hepcidin by mild inflammation. Splenic ferroportin was increased probably to sustain hematopoiesis. Overall, our results indicate that Pfn2 expression is controlled by the IRPs in vivo and that Pfn2 contributes to maintaining iron homeostasis in cell lines and mice.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28774878     DOI: 10.1182/blood-2016-11-754382

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  [Profilin 2 is highly expressed in gastric cancer and promotes tumor cell proliferation and migration].

Authors:  S Hu; L Shi
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-02-20

Review 2.  Transferrin receptor 1 in cancer: a new sight for cancer therapy.

Authors:  Ying Shen; Xin Li; Dandan Dong; Bin Zhang; Yanru Xue; Peng Shang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

3.  MicroRNA-dependent inhibition of PFN2 orchestrates ERK activation and pluripotent state transitions by regulating endocytosis.

Authors:  Carolyn Sangokoya; Robert Blelloch
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-11       Impact factor: 11.205

4.  Differential translational control of 5' IRE-containing mRNA in response to dietary iron deficiency and acute iron overload.

Authors:  Kerry R Garza; Stephen L Clarke; Yi-Hsuan Ho; Matthew D Bruss; Aparna Vasanthakumar; Sheila A Anderson; Richard S Eisenstein
Journal:  Metallomics       Date:  2020-12-23       Impact factor: 4.526

Review 5.  Mechanisms of cellular iron sensing, regulation of erythropoiesis and mitochondrial iron utilization.

Authors:  Nunziata Maio; De-Liang Zhang; Manik C Ghosh; Anshika Jain; Anna M SantaMaria; Tracey A Rouault
Journal:  Semin Hematol       Date:  2021-06-27       Impact factor: 3.754

Review 6.  Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer.

Authors:  Liangfu Zhou; Bin Zhao; Lixiu Zhang; Shenghang Wang; Dandan Dong; Huanhuan Lv; Peng Shang
Journal:  Int J Mol Sci       Date:  2018-05-22       Impact factor: 5.923

7.  Ubiquitin-Proteasome System Is Required for Efficient Replication of Singapore Grouper Iridovirus.

Authors:  Xiaohong Huang; Shina Wei; Songwei Ni; Youhua Huang; Qiwei Qin
Journal:  Front Microbiol       Date:  2018-11-26       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.